Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 17, 2009Clinical Pharmacology & TherapeuticsOpen Access

The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin

View Full Paper
Ask AI
Bookmark
Share

Authors

MTMladen V. TzvetkovUniversitätsmedizin GreifswaldSVStefan Viktor VormfeldeNovartis (Switzerland)DBDaniela BalenInstitute for Medical Research and Occupational Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Tzvetkov et al. (2009) studied this question.

synapsesocial.com/papers/6aa9310ed7d677827e255ab3https://doi.org/10.1038/clpt.2009.92
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine2003 · 272 citations
  2. 2Genomewide Linkage Analysis to Serum Creatinine, GFR, and Creatinine Clearance in a Community-Based Population2004 · 172 citations
  3. 3Pax Transactivation-Domain Interacting Protein Is Required for Urine Concentration and Osmotolerance in Collecting Duct Epithelia2007 · 26 citations
  4. 4Metformin is a Superior Substrate for Renal Organic Cation Transporter OCT2 rather than Hepatic OCT12005 · 361 citations
  5. 5Metformin kinetics in healthy subjects and in patients with diabetes mellitus.1981 · 501 citations